StockWatch
·

BERYL DRUGS LTD. Q2 FY26 Results

BERLDRGQ2 FY26 Results
Filing
MetricValue ( Cr)Q1 FY26Q2 FY25
Revenue5.126.8%8.8%
Total Income5.166.6%8.7%
Expenditure4.902.7%11.6%
PBT0.26273.5%141.0%
Net Profit0.0157.8%27.1%
OPM13.58%2.94pp20.37pp
NPM0.17%0.27pp0.05pp
EPS0.0250.0%100.0%
View full financials

Informational and educational content only. Not investment advice.